The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, ...

Levity, an online pharmacy that sells GLP-1 medications like Ozempic, Wegovy, and Mounjaro, recently did a study of 1,000 women in the ... work after their GLP-1 weight loss.

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound ... loss in adults with a BMI of 30 or higher if they have a related condition like ...

Novo Nordisk's Wegovy, a weight loss drug, will soon be accessible to ... or other procedures that use anesthesia or deep sedation. Pregnant women and those who plan to get pregnant are also ...

like Hims & Hers (HIMS), to increase access to Wegovy. Novo also scored an exclusive deal to be listed as the preferred weight-loss drug for coverage on CVS's (CVS) formulary. This caused Lilly's ...